PathomIQ Inc., headquartered in Silicon Valley ,USA, was founded by a team of outstanding biomarker discovery researchers, data scientists and clinicians with extensive experience in their areas of specialty.
Core Team

Rajat Roy
Serial Entrepreneur with two successful startup exits
Business and Technology Leader in Enterprise AI/ML applications and computing

George Wilding, MD
Former Vice Provost of Multidisciplinary Clinical Research, MD Anderson Cancer Center
Former Director, UW Carbone Cancer Center

Parag Jain
AI and High Performance Computing

Wei Huang, MD
Professor of Pathology, UW Carbone Cancer Center
Post Doctoral Fellow, Harvard / Brigham Women Hospital

Hirak Basu, PhD
Chair, DoD PCRP and NIH Study Sections
Former MD Anderson, UW Madison

Shivaani Kummar, MD
Chair of Cancer Research, OHSU/KCI
Co-Director of Center of Experimental Therapeutics, Knight Cancer center, ex Prof Stanford Medical and Yale

Hassan Muhammad, PhD
Former Scientist, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine

Ratnakar Malla
Former Software Executive at Oracle and Carta Healthcare
Cloud computing and enterprise scale software

Chao Feng, PhD
Former Scientist, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine
Scientific Advisory Board

Debashish Roychowdhury, MD
Former Sr VP, Head of Global Oncology Drug Development Sanofi, GSK, Eli Lilly

Ramandeep Randhawa, PhD
Stanford University, PhD

Janak Desai, MS, MCh, FRCS
Honorary member of German, UK & Japan Urological Society

Chris Parker
Former Chief Business Officer, Adella, Business Development and Commercialization Executive at Exact Sciences, GE Healthcare, Affymetrix